Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamate Infusion in Hypertrophied Ventricle After AVR
NCT01144039Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Feb 2006
- Primary completion
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Glutamic acid in Myocardial ischemia (MI) (3 arms), sponsored by Medical University of Vienna. Primary endpoints: Flow propagational velocity at 6 hours, Isovolumic relaxation time at 6 hours and 3 more. Started Feb 2006; status: completed.
02
Drugs
Glutamic acid
03
Conditions
Myocardial ischemia (MI)
Beyond the preview
Go deeper on NCT01144039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01144039.